Compounds

US6969710B2 · kind B2 · utility

Assignee

• Biovitrum AB · SE

Inventors

• Ulf Bremberg · Upplands Väsby, SE
• Patrizia Caldirola · Uppsala, SE
• Annika Jensen · Uppsala, SE
• Gary Johansson · Hockessin, US
• Andrew Mott · Knivsta, SE
• Lori Sutin · Knivsta, SE
• Jan Tejbrant · Stuvsta-Snättringe, SE

Key dates

• Filing date: May 13, 2002
• Grant date: Nov 29, 2005
• Expiry date: May 13, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/08
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.